On Oct 25, major Wall Street analysts update their ratings for $Keurig Dr Pepper (KDP.US)$, with price targets ranging from $40 to $42.
Citi analyst Filippo Falorni maintains with a buy rating, and adjusts the target price from $43 to $40.
Wells Fargo analyst Christopher Carey maintains with a buy rating, and adjusts the target price from $43 to $42.
RBC Capital analyst Nik Modi maintains with a buy rating, and adjusts the target price from $41 to $42.
Truist Financial analyst Bill Chappell maintains with a hold rating.
Furthermore, according to the comprehensive report, the opinions of $Keurig Dr Pepper (KDP.US)$'s main analysts recently are as follows:
Keurig Dr Pepper's performance in the U.S. coffee segment during Q3 was characterized as unsatisfactory, with reported sales and profits not meeting expectations, despite a more positive outcome in the U.S. refreshment beverage sector. The shortfall in the coffee division is largely attributed to unfavorable pricing dynamics, accompanied by a less than anticipated volume of coffee pod sales. Nonetheless, the general valuation of Keurig Dr Pepper is still considered appealing.
Keurig Dr Pepper's recent quarter performance was subdued due to an aggressive promotional climate in the coffee sector and international outcomes that marginally missed projections. Nonetheless, the firm's total volumes have seen acceleration for the third successive quarter, and its earnings per share aligned with expectations.
The third quarter showed satisfactory performance, and expectations are poised for the company to meet its long-term targets by 2025. The recent agreement with GHOST is anticipated to contribute approximately 300 basis points to growth, with an expected mid-teens EBITDA margin, and it also provides the flexibility to strategically adapt within the coffee segment, positioning the company favorably.
Here are the latest investment ratings and price targets for $Keurig Dr Pepper (KDP.US)$ from 4 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
美东时间10月25日，多家华尔街大行更新了$Keurig Dr Pepper (KDP.US)$的评级，目标价介于40美元至42美元。
花旗分析师Filippo Falorni维持买入评级，并将目标价从43美元下调至40美元。
富国集团分析师Christopher Carey维持买入评级，并将目标价从43美元下调至42美元。
加皇资本市场分析师Nik Modi维持买入评级，并将目标价从41美元上调至42美元。
储亿银行分析师Bill Chappell维持持有评级。
此外，综合报道，$Keurig Dr Pepper (KDP.US)$近期主要分析师观点如下：
Keurig Dr Pepper在第三季度的美国咖啡板块表现被描述为不理想，报告的销售和利润未达预期，尽管在美国饮料板块有更积极的结果。咖啡部门的缺口主要归因于不利的定价动态，以及比预期少的咖啡豆销量。尽管如此，Keurig Dr Pepper的总体估值仍被认为具有吸引力。
由于咖啡行业竞争激烈以及国际业绩略低于预期，Keurig Dr Pepper最近的季度表现低调。尽管如此，公司的总成交量连续第三个季度增长，并且每股收益与预期一致。
第三季度表现令人满意，预计公司将于2025年实现长期目标。最近与GHOSt达成的协议预计将为增长贡献约300个基点，预期的中位数EBITDA利润率为中低两位数，并为在咖啡板块内进行战略调整提供了灵活性，有利于公司地位。
以下为今日4位分析师对$Keurig Dr Pepper (KDP.US)$的最新投资评级及目标价：
提示:
TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。
